Androgen replacement in women: a commentary.
暂无分享,去创建一个
[1] Frederick C W Wu,et al. WHICH ANDROGEN REPLACEMENT THERAPY FOR WOMEN , 1999 .
[2] H. Burger,et al. The rationale for physiological testosterone replacement in women. , 1998, Bailliere's clinical endocrinology and metabolism.
[3] D. Schoenfeld,et al. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. , 1998, The Journal of clinical endocrinology and metabolism.
[4] H. Burger,et al. Should women be treated with testosterone? , 1998, Clinical endocrinology.
[5] S. Davis. The clinical use of androgens in female sexual disorders. , 1998, Journal of sex & marital therapy.
[6] S. Cummings,et al. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. , 1998, The Journal of clinical endocrinology and metabolism.
[7] G G Klee,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estroge , 2022 .
[8] T. Su,et al. Pituitary–adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls , 1998, Biological Psychiatry.
[9] E. Simpson,et al. Aromatase expression of human osteoblast-like cells , 1998, Molecular and Cellular Endocrinology.
[10] E. Engleman,et al. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. , 1998, The Journal of rheumatology.
[11] L. Nelson,et al. Bone Loss in Young Women With Karyotypically Normal Spontaneous Premature Ovarian Failure , 1998, Obstetrics and gynecology.
[12] J. D. Wagner,et al. Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[13] J. Jacobs,et al. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. , 1996, Annals of the rheumatic diseases.
[14] H. Burger,et al. Clinical review 82: Androgens and the postmenopausal woman. , 1996, The Journal of clinical endocrinology and metabolism.
[15] N. Santoro,et al. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. , 1996, Fertility and sterility.
[16] Wilder Rl. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. , 1996 .
[17] O. Ylikorkala,et al. High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement. , 1996, The Journal of clinical endocrinology and metabolism.
[18] M. Adams,et al. Methyltestosterone Does Not Diminish the Beneficial Effects of Estrogen Replacement Therapy on Coronary Artery Reactivity in Cynomolgus Monkeys , 1996 .
[19] C. Slemenda,et al. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. , 1996, The Journal of clinical investigation.
[20] R. Wilder. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. , 1996, The Journal of rheumatology. Supplement.
[21] S. Schwartz,et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. , 1996, The Journal of clinical endocrinology and metabolism.
[22] B. Winblad,et al. Estradiol and testosterone in specific regions of the human female brain in different endocrine states , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[23] A. Masi,et al. Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems. , 1995, Seminars in arthritis and rheumatism.
[24] D. Horsfall,et al. Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] G. Secreto,et al. Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[26] N. Watts,et al. Comparison of Oral Estrogens and Estrogens Plus Androgen on Bone Mineral Density, Menopausal Symptoms, and Lipid‐Lipoprotein Profiles in Surgical Menopause , 1995, Obstetrics and gynecology.
[27] H. Burger,et al. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. , 1995, Maturitas.
[28] W. Rosner,et al. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. , 1995, The Journal of clinical endocrinology and metabolism.
[29] J. Born,et al. Selective influence of menstrual cycle on perception of stimuli with reproductive significance. , 1994, Psychosomatic medicine.
[30] L. Speroff,et al. A Comparison of Esterified Estrogens With and Without Methyltestosterone: Effects on Endometrial Histology and Serum Lipoproteins in Postmenopausal Women , 1993, Obstetrics and gynecology.
[31] C. Roselli,et al. Aromatase activity in the rat brain: Hormonal regulation and sex differences , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[32] M. Savvas,et al. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens. , 1993, British journal of obstetrics and gynaecology.
[33] G. Bachmann,et al. Sexuality in sexagenarian women. , 1991, Maturitas.
[34] M. Horowitz,et al. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women. , 1989, Archives of internal medicine.
[35] C. Mortimer,et al. Skeletal effects of oestrogen and testosterone in postmenopausal women , 1988, BMJ.
[36] H. Burger,et al. Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women: , 1987 .
[37] R. Mathur,et al. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. , 1985, Maturitas.
[38] B. Sherwin,et al. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. , 1985, Psychosomatic medicine.
[39] R. Bryan,et al. Androgen receptors in breast cancer , 1984, Cancer.
[40] H. Burger,et al. The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results. , 1984, Maturitas.
[41] D. Rubinow,et al. Premenstrual syndromes: overview from a methodologic perspective. , 1984, The American journal of psychiatry.
[42] G. Strain,et al. Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. , 1980, The Journal of clinical endocrinology and metabolism.
[43] H. Jacobs,et al. PLASMA HORMONE PROFILES IN POST‐MENOPAUSAL WOMEN BEFORE AND DURING OESTROGEN THERAPY , 1977 .
[44] S. Campbell,et al. Oestrogen therapy and the menopausal syndrome. , 1969, Clinics in obstetrics and gynaecology.
[45] H. Judd. HORMONAL DYNAMICS ASSOCIATED WITH THE MENOPAUSE , 1976, Clinical obstetrics and gynecology.
[46] G. Abraham. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. , 1974, The Journal of clinical endocrinology and metabolism.
[47] Utian Wh. The true clincal features of postmenopause and oöphorectomy, and their response to oestrogen therapy. , 1972 .
[48] W. Utian. The true clincal features of postmenopause and oöphorectomy, and their response to oestrogen therapy. , 1972, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[49] S. Yrarrázaval,et al. [The climacteric]. , 1957, Revista medica de Chile.